English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Fedorchenko M.V.

    EVALUATION OF PHARMACOLOGICAL POSTCONDITIONING BY ARGININE/LEVOCARNITINE IN PATIENTS WITH STEMI/NSTEMI


    About the author: Fedorchenko M.V.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The aim of the research was to study the effect of the pharmacological postconditioning by the combined drug consisting of arginine hydrochloride and levocarnitine and its echocardiographic evaluation. In addition the standard treatment scheme of arginine/levocarnitine does not influence on the myocardial remodeling (dynamics to the eccentric myocardial hypertrophy/remodeling). Meanwhile, the myocardial reserve index credibly increases by 4%. Confirmation of the non-sufficient positive influence of the researched drug on the processes of remodeling, hypertrophy and contractility is the WMSI dynamics: from 1.74±0.07 before treatment to 1.70±0.05 (ВР=0.70 [95% ДІ 0.47-1.04; р=0.66]). Still, the LVEF increased by 4.4% (by Teicholz).
    Tags myocardial infarction, myocardial conditioning, postinfarction remodeling
    Bibliography
    • Vatutin NT, Kolesnikov VS. Vliyaniye preparata advokard na techeniye ostrogo koronarnogo sindroma s elevatsiyey segmenta ST. Líki Ukrayiny. 2013; 9-10: 67-69. [in Russian]
    • Mokhort M, Kutovyy Yu. Prekondytsiyuvannya miokarda (ohlyad literatury). Zhurnal NAMN Ukrayiny. 2014; 20-2: 160-171. [in Ukrainian]
    • Sokolov MYu. Reyestr perkutannykh koronarnykh vmeshatelstv: rasshirennyi sravnitelnyi analiz rezultatov 2016 i 2017 goda. Ot reperfuzionnogo paradoksa k snizheniyu letalnosti. Sertse i sudyny. 2018;3:9-27. [in Russian]
    • Bulluck H, et al. Reducing myocardial infarct size: challenges and future opportunities. Heart. 2016; 102:341-348.
    • Garcia-Dorado D, Ruiz-Meana M, Inserte J, Rodriguez-Sinovas A, Piper HM. Calcium-mediated cell death during myocardial reperfusion. Cardiovascular Research.2012; 94(2):168-180.
    • Hartley A, Marshall DC, Salciccioli JD, Sikkel MB, Maruthappu M, ShalhoubJ. Trends in mortality from ischemic heart disease and cerebrovascular disease in Europe: 1980 to 2009. Circulation. 2016; 133(20):1916–1926.
    • Hausenloy DJ, Yellon DM. Myocardial ischemia–reperfusion injury: a neglected therapeutic target. Journalof Clinical Investigation. 2013; 123(1):92-100.
    • Lebeau R, Serri K., Lorenzo MD. Assessment of LVEF using a new 16-segment wall motion score in echocardiography. Echo Res Pract. 2018; 5(2): 63-69. (10.1530/ERP-18-0006)
    • Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning and translational aspects of protective measures. American Journal of Physiology – Heart and Circulatory Physiology. 2011; 301: H1723-H1741.
    • Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. European Heart Journal. 2016; 37(42):3232–3245.
    Publication of the article «World of Medicine and Biology» №3(69), 2019 year, 162-167 pages, index UDK 616.127-005.8:616-08-031.81:616-71
    DOI 10.26724/2079-8334-2019-3-69-162-167